CDH1 and breast cancer: The previous literature has identified five mechanisms of E-cadherin inactivation in breast cancer: (i) mutation, (ii) a loss of heterozygosity, (iii) promoter methylation, (iv) transcriptional repression, and (v) post-translational modifications (such as aberrant glycosylation) [25].